Evidence map›Paper›PMID 32256588›Full record

ArticleJournal of oncology2020

Saponin Facilitates Anti-Robo1 Immunotoxin Cytotoxic Effects on Maxillary Sinus Squamous Cell Carcinoma.

Noriko Komatsu, Miku Komatsu, Riuko Ohashi, Akira Horii, Kazuto Hoshi, Tsuyoshi Takato, Takahiro Abe, Takao Hamakubo

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Animals : an open access journal from MDPI · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Noriko KomatsuDepartment of Oral and Maxillofacial Surgery, The University of Tokyo Hospital, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Miku KomatsuDepartment of Molecular Patology, Tohoku University of School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
Riuko OhashiHistopathology Core Facility, Niigata University Faculty of Medicine, Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.
Akira HoriiDepartment of Molecular Patology, Tohoku University of School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
Kazuto HoshiDepartment of Oral and Maxillofacial Surgery, The University of Tokyo Hospital, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Tsuyoshi TakatoDepartment of Oral and Maxillofacial Surgery, The University of Tokyo Hospital, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Takahiro AbeDepartment of Oral and Maxillofacial Surgery, The University of Tokyo Hospital, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0003-1251-7448
Takao HamakuboDepartment of Protein-protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kosugi-cho, Nakahara-ku, Kawasaki 211-8533, Japan.ORCID https://orcid.org/0000-0003-1353-8902
University of Tokyo Hospital · JPTohoku University · JPNiigata University Medical and Dental Hospital · JPNippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers worldwide. The standard treatment of surgery, chemotherapy, and radiotherapy can result in long-term complications which lower the patient's quality of life, such as eating disorders, speech problems, and disfiguring or otherwise untoward cosmetic issues. Antibody therapy against cancer-specific antigens is advantageous in terms of its lesser side effects achieved by its greater specificity, though the antitumor activity is still usually not enough to obtain a complete cure. Robo1, an axon guidance receptor, has received considerable attention as a possible drug target in various cancers. We have shown previously the enhanced cytotoxic effects of saporin-conjugated anti-Robo1 immunotoxin (IT-Robo1) on the HNSCC cell line HSQ-89 in combination with a photochemical internalization technique. Considering the light source, which has only limited tissue penetrance, we examined the drug internalization effect of saponin. Treatment with saponin facilitated significant cytotoxic effects of IT-Robo1 on HSQ-89 cells. Saponin exerts its own nonspecific cytotoxicity, which may cover the actual extent of the internalization effect. We thus examined whether a flashed treatment with saponin exerted a significant specific cytotoxic effect on cancer cells. The combination of an immunotoxin with saponin also exhibited a significant tumor-suppressive effect on mice HSQ-19 xenografts. These results suggest the utility of saponin treatment as an enhancer of immunotoxin treatment in cancer.

Identifiers

PMID32256588
PMCPMC7086449
OpenAlexW3012270820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.